Co-modulation of finely tuned high-gamma band activity across hemispheres in Parkinson's disease

帕金森病中大脑半球间精细调控的高伽马波段活动的协同调节

阅读:1

Abstract

OBJECTIVE: Dopaminergic treatment of patients with Parkinson's disease can be associated with a finely tuned high-gamma (FTG) band oscillation between 60 and 90 Hz in the basal ganglia (BG) nuclei. This activity, together with suppression of excessive neural synchrony in the beta frequency band (15-30 Hz), is hypothesized to contribute to the pro-kinetic effects of dopaminergic medication. Beta activity, which high-gamma replaces, has been shown to be bilaterally coherent, but whether sub-cortical FTG activity is in some way linked across hemispheres remains unknown. METHODS: We analyse bilateral local field potential activity recorded from the subthalamic nuclei of 10 patients on dopaminergic medication while at rest, following surgery for deep brain stimulation. RESULTS: In three of these patients FTG activities were coherent across the hemispheres. Short duration (≤18 s) bilateral amplitude and frequency co-modulation were recorded in all subjects, although the two phenomena were independent in time and independent of similar episodes in other frequency bands. CONCLUSIONS: FTG co-modulation can be independent of movement and of co-modulation episodes at other frequencies. SIGNIFICANCE: Relatively independent organisation of processing through amplitude and frequency modulation within different frequency bands potentially affords opportunities for functional segregation and multiplexing of processing streams within the BG.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。